The Application of the Accelerated Stability Assessment Program (ASAP) to Quality by Design (QbD) for Drug Product Stability


An isoconversion paradigm, where times in different temperature and humidity-controlled stability chambers are set to provide a fixed degradant level, is shown to compensate for the complex, non-single order kinetics of solid drug products. A humidity-corrected Arrhenius equation provides reliable estimates for temperature and relative humidity effects on degradation rates. A statistical protocol is employed to determine best fits for chemical stability data, which in turn allows for accurate estimations of shelf life (with appropriate confidence intervals) at any storage condition including inside packaging (based on the moisture vapor transmission rate of the packaging and moisture sorption isotherms of the internal components). These methodologies provide both faster results and far better predictions of chemical stability limited shelf life (expiry) than previously possible. Precise shelf-life estimations are generally determined using a 2-week, product-specific protocol. Once the model for a product is developed, it can play a critical role in providing the product understanding necessary for a quality by design (QbD) filing for product approval and enable rational control strategies to assure product stability. Moreover, this Accelerated Stability Assessment Program (ASAP) enables the coupling of product attributes (e.g., moisture content, packaging options) to allow for flexibility in how control strategies are implemented to provide a balance of cost, speed, and other factors while maintaining adequate stability.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. 1.

    Waterman KC, Adami RC. Accelerated aging: prediction of chemical stability of pharmaceuticals. Int J Pharm. 2005;293:101–25.

    PubMed  Article  CAS  Google Scholar 

  2. 2.

    Baertschi SW, Jansen PJ. Stress testing: a predictive tool. Drugs and the Pharm Sci. 2005;153:13–49 (Pharmaceutical Stress Testing).

    Article  CAS  Google Scholar 

  3. 3.

    Waterman KC, Carella AJ, Gumkowski MJ, Lukulay P, MacDonald BC, Roy MC, et al. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms. Pharm Res. 2007;24(4):780–90.

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Waterman KC. Understanding and predicting pharmaceutical product shelf-life. In: Huynhba K, editor. Handbook of stability testing in pharmaceutical development: regulations, methodologies and best practices. New York: Springer; 2008. p. 115–35. Chapter 6.

    Google Scholar 

  5. 5.

    Waterman KC. Unpublished results presented at American Association of Pharmaceutical Sciences National Meeting, New Orleans, 2010.

  6. 6.

    Waterman KC, MacDonald BC. Package selection for moisture protection for solid, oral drug products. J Pharm Sci. 2010;99:4437–52.

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Naveršnik K, Bohanec S. Predicting drug hydrolysis based on moisture uptake in various packaging designs. Eur J Pharm Sci. 2008;35:447–56.

    PubMed  Article  Google Scholar 

  8. 8.

    Allinson JG, Dansereau RJ, Sakr A. The effects of packaging on the stability of a moisture sensitive compound. Int J Pharm. 2001;221:49–56.

    PubMed  Article  CAS  Google Scholar 

  9. 9.

    Badawy SIF, Gawronski AJ, Alvarez FJ. Application of sorption-desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations. Intern J Pharm. 2001;223(1–2):1–13.

    Article  CAS  Google Scholar 

  10. 10.

    Roskar R, Kmetec V. Evaluation of the moisture sorption behavior of several excipients by BET, GAB and microcalorimetric approaches. Chem Pharm Bull. 2005;53(6):662–5.

    PubMed  Article  CAS  Google Scholar 

  11. 11.

    Dalton CR, Hancock BC. Processing and storage effects on water vapor sorption by some model pharmaceutical solid dosage formulations. Intern J Pharm. 1997;156:143–51.

    Article  CAS  Google Scholar 

  12. 12.

    Yeshwant YL, Sanzgiri D, Chen Y. A study on moisture isotherms of formulations: the use of polynomial equations to predict the moisture isotherms of tablet products. AAPS PharmSciTech. 2003;4:1–8. Article 59.

    Google Scholar 

  13. 13.

    Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25:781–91.

    PubMed  Article  CAS  Google Scholar 

  14. 14.

    Govindarajan R, Zinchuk A, Hancock B, Shalaev E, Suryanarayanan R. Ionization states in the microenvironment of solid dosage forms: effect of formulation variables and processing. Pharm Res. 2006;23:2454–68.

    PubMed  Article  CAS  Google Scholar 

  15. 15.

    Waterman KC, Colgan ST. A science-based approach to setting expiry dating for solid drug products. Regulatory Rapporteur. 2008;5:9–14.

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Kenneth Craig Waterman.

Additional information

Guest Editors: Robin Bogner, James Drennen, Mansoor Khan, Cynthia Oksanen, and Gintaras Reklaitis

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Waterman, K.C. The Application of the Accelerated Stability Assessment Program (ASAP) to Quality by Design (QbD) for Drug Product Stability. AAPS PharmSciTech 12, 932 (2011).

Download citation


  • accelerated aging
  • QbD
  • shelf life
  • stability